看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
& l% @& @# D8 C0 b2 W; D6 ?0 ` Q. |5 }( h* x* i5 n3 ~( h
! s4 _* @% Y! B% FCurrently available feasibility data for possible combination strategies.
! R8 `' `+ z p————————————————————————————————7 g2 D2 D: O' r
Combination Feasibility according to preliminary data
9 z, w u& F O. m0 A: }# A z4 P——————————————————————————————————. ~/ G8 v* d: o
Bevacizumab + sorafenib Yes, reduced dose ) n% l; f: ]0 @+ m: h) H+ J) {6 d% q0 m
Bevacizumab + sunitinib† No 2 X: p0 |7 A/ i4 i! Z: N4 Q
Bevacizumab + temsirolimus Yes
+ U; P( m$ z# n& x, `- EBevacizumab + everolimus Yes + ~ i, ` [/ f8 c3 J
Sorafenib + sunitinib ?
+ z- d) Z) @7 J+ ]; iSorafenib + temsirolimus Yes, reduced dose
5 L m/ n7 }* }2 D& L) {2 dSorafenib + everolimus Yes, reduced dose
' I. \( d& l: M! wSunitinib + temsirolimus† No
& k3 n$ }+ u$ M! o' [9 Y- hSunitinib + everolimus ?
( p5 S+ j- o) s7 r' G ~1 q" VTemsirolimus + everolimus ?
" M+ R9 Z6 ^- c7 D2 a————————————————————
( r8 o" w; ?5 M' b" j†Led to US FDA warning.' ]" w4 M8 ~/ @% W1 b% r J
?: As yet unattempted combination.5 D6 ?9 s: g- z: T n0 ~1 Y
|